ClinicalTrialsFinder

Adrenal Cortical Cancer Clinical Trials in Chengdu, Sichuan

1 recruitingChengdu, Sichuan, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma

Adrenal Cortical CancerAdrenal Cortical CarcinomaAdrenal Cancer
West China Hospital28 enrolled1 locationNCT06831175